Nong Lin1 ,
Qiaolu Yang1,
Tong Xu2,
Lianguo Shi3
For correspondence:- Nong Lin Email: NongLinfjk@163.com Tel:+865922137512
Accepted: 30 January 2020 Published: 29 February 2020
Citation: Lin N, Yang Q, Xu T, Shi L. Evaluation of chidamide and PFI-1 as a combination therapy for triple-negative breast cancer. Trop J Pharm Res 2020; 19(2):259-264 doi: 10.4314/tjpr.v19i2.7
© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates